News - Selux Diagnostics

In the News

How New Rapid Antimicrobial Susceptibility Testing Technologies for Blood Cultures Change the Paradigm of Patient Care

January 28, 2025

Does Speed Matter? The Financial and Clinical Benefits of Rapid AST

January 28, 2025

Changing the paradigm of patient care with new rapid antimicrobial susceptibility testing technologies

January 28, 2025

Rapid AST is here to stay: Multi-site comparison of performance and time-to-results of rapid and legacy AST Systems with “gold standard” methods.

January 28, 2025

Selux Diagnostics Announces Additional $48 Million in Funding

April 1, 2024

The Selux PBC Separator With Selux AST System Receives FDA 510(k) Clearance for Rapid Antibiotic Susceptibility Testing Direct From Positive Blood Culture

February 26, 2024

Selux Receives FDA Clearance on Their Gram-Negative Panel

June 16, 2023

FDA Clears ‘Selux NGP System’ for Rapid Antibiotic Susceptibility Testing

January 19, 2023

Dr. James S. Lewis II, Antibiotic Susceptibility Test Expert, Joins as Chair of Selux Diagnostics’ Clinical Advisory Board

October 18, 2022